Purchase access and get detailed insights on all of the companies below via CEO presentations (audio and slides), executive summaries, and much more. Plus leverage our private partnering tool to request additional information and meetings with CEOs.
AIT Therapeutics - AIT has a nitirc oxide (NO) generator and delivery system. The device generates NO from ambient air and can deliver it to a patient's lungs via a breathing circuit and mask or through a ventilator. The device is powered through any standard electrical outlet and should, upon certain regulatory approvals, be used anywhere in the hospital or at home.
(View Sample Presentation) Alpha Tau Medical - Alpha Tau Medical focuses on research, development, and commercialization of Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) for the treatment of solid tumors.
(View Sample Presentation) Auctus Surgical - Auctus is developing a system to treat pediatric scoliosis with non-fusion surgical system - an internal brace or sorts. Our growth modulation system includes a tether affixed to the anterior/lateral portion of the vertebral bodies. As the child grows the spine straightens over time. Our system includes a non-surgical adjustable component that allows for further increasing or reduction in tension over time.
(View Sample Presentation) BeamLine Diagnostics - BeamLine develops real-time, point-of-care clinical screening systems that streamline diagnostic pathways enabling the expansion of life-saving screening programmes
(View Sample Presentation) Cellgen Diagnostics - Cellgen is developing the industry's first precision medicine platform for immuno-oncology therapeutics. Cellgen's technology measures the genetic expression of a patient's immune system to determine if that patient is likely to respond to the given immunotherapy...all in just 2 hours.
(View Sample Presentation) EarlyCell - First-in-class breakthrough technology for isolation of rare fetal cells directly from maternal blood to enable complete prenatal genetic and other diagnosis. Unique access to entire information content available only in an intact fetal cell for medical diagnosis, decisions, and for upcoming in utero gene therapy. Technology in last stages of clinical trials, including human trials in early 2019.
(View Sample Presentation) Elbe Valley Medical - We are developing a therapy for treating large and aggressive cancer tumours which are beyond treatment with conventional therapies.
(View Sample Presentation) Embody - Embody is a medical device company developing collagen-based implants for the treatment of tendon and ligament injuries.
(View Sample Presentation) HIL Applied Medical - HIL Applied Medical is developing ultra-compact, high-performance systems for cancer Proton Therapy.
(View Sample Presentation) Prima-Temp - Prima-temp has developed Priya, a novel device designed to measure core body temperature in women trying to conceive. 'Why guess when you can know' your fertile window.
(View Sample Presentation) Promaxo - Promaxo is a medical technology company that develops and commercializes office-based modular MRI and MRI based technologies. The Company is currently focused on advancing the solutions for prostate disease management and other urology and pelvic conditions.
(View Sample Presentation) Sparo - Sparo has developed Lift Pulmonary Rehab a digital, home-based rehab program designed for seniors, helping increase energy and endurance, reduce shortness of breath, and improve quality of life.
(View Sample Presentation) TAS Medical - TAS Medical will revolutionize abdominal surgery. We are dedicated to saving healthcare millions of dollars while improving the outcomes of ventral hernia repair. Our mission is to provide an alternative to mesh for ventral hernia repairs. Convert ventral hernia procedures from a costly open repair to a minimally invasive laparoscopic repair. Develop first to market tension measurement device for abdominal surgery. Our Trans Abdominal Strap has the strong potential to eliminate the need for mesh in many ventral hernia repairs and to convert procedures from a highly morbid open surgery to a minimally invasive laparoscopic surgery.
(View Sample Presentation) TBA - More companies coming soon
Sample EMT Spotlight Profile
Below is a sample profile from our last event. This type of insight is available for every company being profiled in our upcoming Spotlight.
Presenter: Boaz Assaf, CEO Financing Status: Seeking Funding Round: Series C Amount: $6-$8M Development Status: CE Marked, Pilot clinical trial completed ready to launch FDA pivotal trial Sales Projection: $7,725,000 in 2021 Seeking Partners: Financing, M&A, Licensing
Need help finding medtech research? Let us help you!